| 产品名称: | Streptococcus tigurinus Zbinden et al. |
|---|---|
| 商品货号: | TS206360 |
| Deposited As: | Streptococcus mitis Andrewes and Horder emend. Judicial Commission |
| Isolation: | Human throat |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties: | Type II |
| Product Format: | freeze-dried |
| Storage Conditions: | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®: | no |
| Type Strain: | no |
| Comments: | Physiological differentiation
The reclassification of this strain to Streptococcus tigurinis is based on 16S gene analysis and acidification of starch. |
| Medium: | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions: | Temperature: 37°C
Atmosphere: Aerobic |
| Name of Depositor: | CK Williamson |
| References: | Facklam RR. Physiological differentiation of viridans streptococci. J. Clin. Microbiol. 5: 184-201, 1977. PubMed: 845245 . Taxonomic biochemistry and serology. New York: Ronald Press; 1964. Zbinden A., et al. Streptococcus tigurinus sp. nov., isolated from blood of patients with endocarditis, meningitis and spondylodiscitis. Int. J. Syst. Evol. Microbiol. 62: 2941-2945, 2012. PubMed: 22357776 |